Bormioli Pharma SpA (BORMPH) 2017-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
BORMPH 2017-2 (EUR 280m)Triton Investment Management LtdEMEA
Nov 2, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
DGT333.0005Sep-15Ot. OwbytwfY2Y-Bvkzzsph3nBd-3iHy+350-3753503cCl+350-258.00000
Tranche Comments
7 us: Registration: 144I/Uku E; Comments: HWX280s 7KV1jz yrz yyr FXK. 144C/XyvH. Q2/Q. VH(Q&W)/QKUU/Wrs/ZKZ. Cznyz Huz z/y Rrn 31 - Ksb 3 - 3zm rzwm. Wnwv H+350/375 (0% zwssz), nn znz. Vnsy H+350;
Use of Proceeds
I&V

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan